Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Type 2 diabetes is a devastating metabolic disorder affecting millions of people worldwide. Deposition of amyloid formed by human islet amyloid polypeptide (IAPP) around pancreatic β-cells is one of the possible causes of the disease. IAPP is a 37-residue peptide expressed by the pancreatic β-cells and cosecreted with insulin, and its misfolding and aggregation into toxic amyloid fibrils are closely linked to β-cell dysfunction. Herein, it is demonstrated that lacmoid effectively inhibits IAPP fibrillation and disaggregates preformed fibrils. Thioflavin T fluorescence in combination with morphological analysis by atomic force microscopy and transmission electron microscopy confirms complete inhibition and disaggregation of IAPP fibrillation at equimolar concentrations of lacmoid. Additionally, circular dichroism and Fourier transform infrared spectroscopy reveal significant changes in the secondary structure of IAPP during fibrillation in the presence of lacmoid. Cytotoxicity assay in U2OS cells show that lacmoid reduces IAPP fibril-induced toxicity. Molecular docking studies further reveal that the Asn14 residue of IAPP plays a critical role in its interaction with lacmoid. The findings collectively highlight the importance of lacmoid as an inhibitor of IAPP fibrillation which may have potential to develop as a drug candidate for the treatment of type 2 diabetes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cbic.202500383 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Role of the extracellular matrix in amylin aggregation: Opportunities for improved therapy in type 2 diabetes mellitus.
J Biosci
September 2025
Cell Metabolism Lab (GA-08), Department of Developmental Biology and Genetics (DBG), Indian Institute of Science (IISc), Bengaluru 560012, India.
In most individuals with type 2 diabetes mellitus (T2DM), aggregation of amylin or islet amyloid polypeptide (IAPP) leads to β-cell apoptosis, impairs glucose-stimulated insulin secretion, and causes islet disorganisation (Cooper . 1987; Westermark and Westermark 2000). Amylin is sorted within the immature secretory granules (ISGs) of pancreatic β-cells and co-secreted with insulin upon nutrient stimulation to regulate metabolism.
View Article and Find Full Text PDFCryo-EM exposes diverse polymorphism in IAPP mutants to guide the rational design of peptide-based therapeutics.
J Mol Biol
August 2025
Department of Chemistry - Ångström Laboratory, Uppsala University, Box 523, Uppsala 751 20, Sweden. Electronic address:
In the pursuit of potential therapeutic agents for type 2 diabetes, non-amyloidogenic forms of the human Islet Amyloid Polypeptide (hIAPP) containing site-specific mutations are of significant interest. In the present study, we dissect the three proline mutations present in the core region of the non-amyloidogenic rat IAPP into single-point mutations at A25P, S28P, and S29P sites. We apply high-resolution cryo-electron microscopy and solve the structures of 6 polymorphs formed by these mutants, revealing the peptide's self-assembly patterns and identifying critical interactions that reinforce these structures in the presence of the β-sheet breaker.
View Article and Find Full Text PDFHigh-throughput discovery of fluoroprobes that recognize amyloid fibril polymorphs.
Nat Chem
August 2025
Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.
Aggregation of microtubule-associated protein tau into conformationally distinct fibrils underpins neurodegenerative tauopathies. Fluorescent probes (fluoroprobes) such as thioflavin T have been essential tools for studying tau aggregation; however, most of them do not discriminate between amyloid fibril conformations (polymorphs). This gap is due, in part, to a lack of high-throughput methods for screening large, diverse chemical collections.
View Article and Find Full Text PDFLacmoid-Induced Conformational Changes Inhibit Fibrillation of Human Islet Amyloid Polypeptide.
Chembiochem
August 2025
School of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067, India.
Type 2 diabetes is a devastating metabolic disorder affecting millions of people worldwide. Deposition of amyloid formed by human islet amyloid polypeptide (IAPP) around pancreatic β-cells is one of the possible causes of the disease. IAPP is a 37-residue peptide expressed by the pancreatic β-cells and cosecreted with insulin, and its misfolding and aggregation into toxic amyloid fibrils are closely linked to β-cell dysfunction.
View Article and Find Full Text PDFPolyphenolic Gallotannins 1,3,6-Tri-O-galloyl-β-d-glucose and Corilagin Attenuate IAPP Amyloid Formation and Cytotoxicity by Primarily Targeting Secondary Nucleation.
Biochemistry
August 2025
Department of Chemistry, Université du Québec à Montréal, 2101 Jeanne-Mance Street, Montreal, Quebec H2X 2J6, Canada.
Protein misfolding and subsequent aggregation into insoluble amyloid deposits are associated with various diseases, including Alzheimer's disease, systemic amyloidosis, and type 2 diabetes mellitus (T2DM). In T2DM, the peptide hormone islet amyloid polypeptide (IAPP), which regulates glucose homeostasis, aggregates in the pancreas, forming soluble cytotoxic aggregates and amyloid fibrils that contribute to β-cell dysfunction and death. Thus, the inhibition of IAPP aggregation consists of a promising strategy for treating T2DM.
View Article and Find Full Text PDF